Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Organ-specific phenotypes of Candida albicans: implications for immunity and pathogenesis.

Created on 06 Aug 2026

Authors

Emma Morris, Lozan Sheriff, Rebecca A Drummond

Published in

Current opinion in microbiology. Volume 93. Pages 102817. Aug 05, 2026. Epub Aug 05, 2026.

Abstract

Organ-specific immune responses are shaped by tissue microenvironments, which instruct and regulate the behaviour of tissue-resident macrophages and lymphocytes. During infection, microbes are also influenced by tissue-specific environmental signals, which may influence host-microbe interactions and infection outcome. The pathogenic fungus Candida albicans undergoes significant adaptation within the host, associated with major genetic and phenotypic changes as a result of stress responses. These underlie the ability of this yeast to evade host immune responses and establish infection. Recent evidence has pointed to C. albicans phenotypic diversity directly influencing the host microenvironment and therefore localised immune responses. In this review, we discuss organ-specific mechanisms of antifungal defence and fungal tissue-specific phenotypes and stress responses during invasive infection. We focus on C. albicans, the best studied fungal infection in multiple organs, while highlighting lessons learned from other fungal pathogens to signal important future directions for the field.

PMID:
42556012
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement